Huntsman Corporation (HUN) | The Buildout — AI Infrastructure
The Verdict
Huntsman is a global manufacturer of diversified organic chemicals across Polyurethanes, Performance Products, and Advanced Materials. Its role in the AI infrastructure buildout is indirect: high-purity amines for semiconductor manufacturing, technical insulation for data centers, and advanced epoxy polymers for power, aerospace, and electrical infrastructure. Management does not frame AI as a central growth engine.
| Market Cap | — |
| Revenue (TTM) | $5.9B |
| Revenue Growth | +0.6% |
| EBITDA Margin (TTM) | 4.9% |
| Net Debt | $1.7B |
| Earnings Beats | 3 of 7 |
| P/E (TTM) | — |
| EV/EBITDA (TTM) | — |
What We Like
- First quarter-on-quarter North American price growth since 2022, with the company aggressively raising prices to expand margins from multi-year trough economics.
- Q2 2026 revenue rose 14.1% year over year to $1,663 million, with gross margin up to 14.7% from 12.9% in Q1 2026.
- Advanced Materials Q1 2026 segment adjusted EBITDA grew to $45 million from $36 million, the clearest organic growth engine in the portfolio.
- Semiconductor specialty amines capacity is in customer qualification, with 2026 revenue expected at $5-plus million and a normalized run rate targeted by end of 2026.
- MDI industry utilization is approaching the high 80s to 90% as a Middle East producer outage removes roughly 4% of global capacity.
What We’re Watching
- H2 2026 demand durability: management says order visibility is clear only through June and expects inflation to pressure consumer demand later in 2026.
- Residential construction: March residential permits were down 11%, a leading-indicator risk to the largest segment, Polyurethanes.
- Olin merger execution: definitive all-stock merger of equals announced June 16, 2026, but no closing date or asset-level integration detail is provided.
- Saudi ethylenamines joint venture: operating around 50%, with quarterly EBITDA impact up to $4.5–5 million and a 30–45 day recovery after any Strait reopening.
The near-term cyclical recovery thesis is strengthening: Q2 revenue accelerated, gross margin improved, and the net loss narrowed sharply. But the reported financial position remains early-stage recovery, and the pending Olin merger shifts the story from standalone cyclical recovery toward merger execution. The open question is whether H2 demand holds enough to sustain the pricing-led margin expansion.
Earnings
Huntsman reported Q2 2026 revenue of $1,663 million, up 14.1% from $1,458 million a year earlier. Gross margin was 14.7%. Net loss attributable to Huntsman narrowed to $6 million from $158 million, and adjusted net income was nil versus an adjusted net loss of $34 million a year earlier.
| Metric | Q2 FY2026 | Q1 FY2026 | Q2 FY2025 | YoY |
|---|---|---|---|---|
| Revenue | $1.7B | $1.4B | $1.5B | +14.1% |
| Gross margin | 14.7% | 12.9% | 12.5% | +220bps |
| EBITDA | $111M | $64M | $61M | +82.0% |
| EPS | $-0.03 | $-0.31 | $-0.92 | −96.2% |
we are aggressively raising our prices to both cover our cost of our raw materials while also expanding margins from the trough economics we have been experiencing for the past three years.— Peter R. Huntsman, Chief Executive Officer, May 1, 2026
Management tone: Management's tone moved from cautious on the Q4 2025 call to more aggressive and action-oriented on the Q1 2026 call. Executives were direct and specific about benzene pass-through, the Saudi joint venture headwind, and the limits of demand visibility, while declining to call Q3.
Management Guidance
On the Q1 2026 call, management set Performance Products Q2 EBITDA guidance at $30–40 million, up from the Q1 actual of $26 million. It projected polyurethanes Q2 raw material costs well in excess of $100 million, with pricing expected to more than offset that. Europe was expected to be EBITDA-positive; specialty amines 2026 revenue was initiated at $5-plus million; and U.S. construction growth was set at 2%–3% low single-digit. Full-year revenue and EPS guidance was not clearly provided.
Trajectory
Revenue trajectory is accelerating. Revenue moved from $1,420 million in Q1 2026 to $1,663 million in Q2 2026, up 17.1% quarter over quarter and 14.1% year over year. Gross margin improved from 12.9% to 14.7%, while adjusted net income reached nil from a prior-year adjusted loss. The bar is hard: trailing four-quarter average revenue growth is only +0.7%, making the Q2 acceleration the clearest signal of cyclical inflection.
The Model
The model projects FY+1 revenue of $5,970 million and EBITDA of $352 million, a 5.9% margin. FY+2 revenue is projected at $6,070 million with EBITDA of $431 million, a 7.1% margin. Near-term is anchored by the Q2 pricing-led recovery and Advanced Materials growth; the FY+2 step-up depends on continued margin expansion as demand holds beyond June.
| Metric | FY2025 | Next FY (E) | Following FY (E) |
|---|---|---|---|
| Revenue | $5.7B | $6.0B | $6.1B |
| YoY Growth | — | +5.1% | +1.7% |
| EBITDA | $248M | $352M | $431M |
| EBITDA Margin | 4.4% | 5.9% | 7.1% |
Projections are the median of 5 independent model runs. The model’s revenue sits 2.5% below analyst consensus.
On the Q1 2026 call, management set Performance Products Q2 EBITDA guidance at $30–40 million, up from the Q1 actual of $26 million. It projected polyurethanes Q2 raw material costs well in excess of $100 million, with pricing expected to more than offset that. Europe was expected to be EBITDA-positive; specialty amines 2026 revenue was initiated at $5-plus million; and U.S. construction growth was set at 2%–3% low single-digit. Full-year revenue and EPS guidance was not clearly provided.
What Could Go Right — and Wrong
- H2 2026 demand holds and price increases stick, lifting revenue above the model's FY+1 projection.
- Specialty amines qualifications complete and 2026 revenue reaches or exceeds the $5-plus million guided level, with a normalized run rate by end of 2026.
- Europe turns EBITDA-positive and then cash-positive, reducing regional drag.
- Olin merger closes and captures the $400 million-plus synergy target on combined EBITDA.
- MDI industry utilization stays in the high 80s to 90% range, preserving pricing power.
- H2 inflation weakens consumer demand, as management warned, causing revenue and pricing to roll over after June.
- Raw material costs stay elevated and Huntsman cannot pass through benzene and natural gas increases.
- Residential construction declines after March permits fell 11%, pressuring Polyurethanes volumes.
- Saudi ethylenamines JV disruption persists beyond the $4.5–5 million quarterly impact.
- Olin merger fails to close or integration falls short of the $400 million-plus synergy expectation.
Looking Ahead
The next 12 months test whether Huntsman's pricing-led cyclical recovery extends beyond June, whether specialty amines qualifications convert into the targeted $5-plus million 2026 contribution, and whether Europe delivers positive EBITDA and eventually positive cash. The Olin merger approvals and closing, with no date disclosed, determine whether the standalone recovery story becomes a merger-execution story.
- Q3 2026Third-quarter order demand — Tests whether June-visibility demand extends and pricing stays ahead of raw materials.
- 2026Specialty amines qualification completions — Confirms $5-plus million semiconductor amines revenue and normalized run rate.
- 2026European polyurethanes positive EBITDA — Tests whether Europe delivers positive EBITDA and eventually positive cash.
- 2026U.S. residential construction data — March permits down 11% either reverse or confirm a construction slowdown.
- If the Strait reopensSaudi ethylenamines JV recovery — 30-45 days to resume full seaborne exports and remove quarterly EBITDA headwind.
- No closing date disclosedOlin merger approvals and closing — Determines whether the standalone recovery story becomes merger execution.
Financials
Annual Summary
| Metric | FY2024 | FY2025 | TTM | YoY |
|---|---|---|---|---|
| Revenue | $6.0B | $5.7B | $5.9B | -5.8% |
| Gross Margin | 14.3% | 13.2% | 13.5% | 108bps |
| EBITDA | $296M | $248M | $7.9B | -16.2% |
| EBITDA Margin | 4.9% | 4.4% | 4.9% | 54bps |
| Net Income | −$189M | −$275M | −$171M | -45.5% |
| Free Cash Flow | $79M | $116M | $4.0B | — |
| Net Cash | — | — | — | — |
Key Ratios (Trailing)
- P/E TTM—
- EV/EBITDA TTM—
- EV/Revenue TTM—
- Price/FCF TTM—
- Gross Margin (TTM)13.5%
- EBITDA Margin (TTM)4.9%
- Net Margin (TTM)-2.9%
- ROIC-0.1%
- FCF Conversion-34.5%
- SBC / Revenue0.7%
The Company
Huntsman is a global manufacturer of diversified organic chemical products across three segments: Polyurethanes (MDI, polyols, TPU), Performance Products (amines, maleic anhydride), and Advanced Materials (epoxy, phenoxy, acrylic, polyurethane, mercaptan, acrylonitrile butadiene-based polymers, carbon nanomaterials). Its products feed industrial and building-product manufacturers across construction, automotive, aerospace, electronics, and coatings. The AI buildout connection is peripheral: high-purity amines for semiconductor manufacturing, technical insulation for data centers, and advanced epoxy polymers for electrical infrastructure and power. The only disclosed AI-adjacent dollar figure is 2026 specialty amines revenue expected at $5-plus million.
Huntsman operates a global manufacturing and R&D footprint that includes MDI sites in Geismar, Louisiana; Rotterdam, the Netherlands; and Caojing, China; amines sites in Freeport, Port Neches, Conroe, Texas, and Jubail, Saudi Arabia; and Advanced Materials formulation and synthesis facilities in the U.S., U.K., Switzerland, and China. It relies on third-party suppliers for benzene, natural gas, and other feedstocks, and the 10-K discloses raw materials with limited or single suppliers. It operates a China PO/MTBE joint venture, now described as a low- to mid-single-digit-million positive contributor, and a Saudi ethylenamines joint venture that was running around 50% in Q1 2026.
Business Segments
Competitive Landscape
Huntsman operates in competitive markets; the supplied material does not include detailed competitor lists by segment. The Q4 2025 call referenced an unnamed competitor adding North American MDI capacity of roughly 2% of global capacity, and an analyst raised a possible Wanhua splitter outage, which management said it had not confirmed as a large-scale outage. The 10-K describes Huntsman's segment positions as leading in its regions, but the source does not describe a sole-source market position.
- Wanhua Chemical GroupAn analyst referenced a possible splitter outage, but management said it had heard no confirmed large-scale outage.
- Unnamed North American MDI competitorAdding North American MDI capacity of roughly 2% of global capacity; market impact may already be felt in Q4 2025/Q1 2026.
Supply Chain
Huntsman sits midstream in the chemicals supply chain, buying benzene, natural gas, and propylene oxide, and selling to industrial, building-product, automotive, aerospace, and electronics customers. Several raw materials have limited or sole-source suppliers.